Certara, Inc. Common Stock
Market Cap
1.2B
Short interest (Jul 15)
19.1%
Net Short (Jul 27 ): 0.1%
Borrow Fee
0.41%
↑ 7.3%
Available Shares
1M
↓ 42.2%
Price Chart
Company Overview
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.